Yin et al. [96] analyzed the serum lncRNA TUG1 levels in the healthy control individuals and multiple myeloma (MM) patients and found that the serum TUG1 expression levels were up-regulated in MM patients, proving that the serum TUG1 levels is a potential diagnostic biomarker. Here, TUG1 is linked to Miyoshi myopathy.